Scottish Medicines Consortium becomes first in UK to adopt new precision gastric cancer treatment - PharmaTimes Decision introduces zolbetuximab for eligible patients in NHS Scotland

#SMC #precisiononcology #precisonmedicine #gastriccancer #zolbetuximab #NHSScotland #AstellasPharma #advancedgastriccancer #gastrooesophagealjunctioncancer #adenocarcinomatumours #biomarkers #cancerbiology #phase3clinicaltrials #SPOTLIGHT #GLOW
zurl.co/7GCPi